HomeCompareUDR vs CME

UDR vs CME: Dividend Comparison 2026

UDR yields 5.11% · CME yields 1.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CME wins by $4.00M in total portfolio value· pulled ahead in Year 4
10 years
UDR
UDR
● Live price
5.11%
Share price
$33.66
Annual div
$1.72
5Y div CAGR
19.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.7K
Annual income
$6,549.10
Full UDR calculator →
CME
CME
● Live price
1.75%
Share price
$297.58
Annual div
$5.20
5Y div CAGR
85.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.05M
Annual income
$3,278,693.93
Full CME calculator →

Portfolio growth — UDR vs CME

📍 CME pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUDRCME
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UDR + CME cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UDR pays
CME pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UDR
Annual income on $10K today (after 15% tax)
$434.34/yr
After 10yr DRIP, annual income (after tax)
$5,566.74/yr
CME
Annual income on $10K today (after 15% tax)
$148.53/yr
After 10yr DRIP, annual income (after tax)
$2,786,889.84/yr
At 15% tax rate, CME beats the other by $2,781,323.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UDR + CME for your $10,000?

UDR: 50%CME: 50%
100% CME50/50100% UDR
Portfolio after 10yr
$2.05M
Annual income
$1,642,621.52/yr
Blended yield
80.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on UDR right now

UDR
Analyst Ratings
18
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$41.10
+22.1% upside vs current
Range: $38.00 — $44.00
Altman Z
0.7
Piotroski
8/9
CME
Analyst Ratings
13
Buy
17
Hold
5
Sell
Consensus: Hold
Price Target
$311.83
+4.8% upside vs current
Range: $300.00 — $340.00
Altman Z
0.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UDR buys
9
CME buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$UDR▼ Sell$15,001 - $50,0002025-10-07
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$UDR▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002025-07-25
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002023-10-31
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-10-10
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-08-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUDRCME
Forward yield5.11%1.75%
Annual dividend / share$1.72$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR19.3%85.4%
Portfolio after 10y$49.7K$4.05M
Annual income after 10y$6,549.10$3,278,693.93
Total dividends collected$25.0K$3.96M
Payment frequencyquarterlyquarterly
SectorREITFinancials
Analyst consensusBuyHold
Analyst price target$41.10$311.83

Year-by-year: UDR vs CME ($10,000, DRIP)

YearUDR PortfolioUDR Income/yrCME PortfolioCME Income/yrGap
1$11,310$609.61$11,024$323.97+$286.00UDR
2$12,870$768.70$12,414$618.83+$456.00UDR
3$14,746$975.32$14,491$1,207.51+$255.00UDR
4← crossover$17,024$1,245.96$17,948$2,442.23$924.00CME
5$19,820$1,603.81$24,445$5,241.07$4.6KCME
6$23,289$2,081.81$38,525$12,368.84$15.2KCME
7$27,647$2,727.39$74,998$33,775.95$47.4KCME
8$33,192$3,609.90$194,178$113,930.22$161.0KCME
9$40,348$4,832.15$718,883$511,112.41$678.5KCME
10$49,721$6,549.10$4,047,898$3,278,693.93$4.00MCME

UDR vs CME: Complete Analysis 2026

UDRREIT

UDR, Inc. (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S. markets. As of September 30, 2020, UDR owned or had an ownership position in 51,649 apartment homes including 1,031 homes under development. For over 48 years, UDR has delivered long-term value to shareholders, the best standard of service to Residents and the highest quality experience for Associates.

Full UDR Calculator →

CMEFinancials

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Full CME Calculator →
📬

Get this UDR vs CME comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UDR vs SCHDUDR vs JEPIUDR vs OUDR vs KOUDR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.